| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 234 | 2024 | 2816 | 25.020 |
Why?
|
| Particulate Matter | 219 | 2024 | 2529 | 20.010 |
Why?
|
| Air Pollution | 164 | 2024 | 2286 | 18.190 |
Why?
|
| Environmental Monitoring | 131 | 2023 | 1414 | 15.560 |
Why?
|
| Air Pollution, Indoor | 63 | 2023 | 857 | 12.240 |
Why?
|
| Environmental Exposure | 139 | 2024 | 4232 | 8.780 |
Why?
|
| Vehicle Emissions | 50 | 2023 | 665 | 8.330 |
Why?
|
| Radon | 12 | 2023 | 81 | 6.720 |
Why?
|
| Particle Size | 108 | 2023 | 1642 | 6.290 |
Why?
|
| Air Pollutants, Radioactive | 9 | 2023 | 46 | 6.190 |
Why?
|
| Radioactivity | 10 | 2023 | 63 | 4.570 |
Why?
|
| Aerosols | 43 | 2022 | 625 | 4.510 |
Why?
|
| Dust | 27 | 2024 | 482 | 4.390 |
Why?
|
| Ozone | 36 | 2024 | 469 | 4.010 |
Why?
|
| Respiratory Tract Diseases | 17 | 2023 | 722 | 3.070 |
Why?
|
| Nitrogen Dioxide | 29 | 2024 | 490 | 2.940 |
Why?
|
| Radiation Monitoring | 5 | 2023 | 98 | 2.800 |
Why?
|
| Inhalation Exposure | 21 | 2020 | 443 | 2.670 |
Why?
|
| Mortality | 27 | 2023 | 2864 | 2.600 |
Why?
|
| Housing | 24 | 2023 | 664 | 2.540 |
Why?
|
| Solar Activity | 7 | 2023 | 37 | 2.420 |
Why?
|
| Seasons | 46 | 2023 | 1493 | 2.390 |
Why?
|
| Trace Elements | 5 | 2022 | 198 | 2.270 |
Why?
|
| Cities | 22 | 2022 | 513 | 2.230 |
Why?
|
| Remote Sensing Technology | 9 | 2021 | 90 | 2.210 |
Why?
|
| Volatile Organic Compounds | 6 | 2023 | 81 | 2.200 |
Why?
|
| Soot | 20 | 2023 | 232 | 2.110 |
Why?
|
| Power Plants | 9 | 2017 | 119 | 2.030 |
Why?
|
| Spacecraft | 9 | 2017 | 27 | 1.960 |
Why?
|
| Temperature | 22 | 2023 | 2204 | 1.950 |
Why?
|
| Weather | 15 | 2019 | 228 | 1.880 |
Why?
|
| Kuwait | 11 | 2023 | 86 | 1.820 |
Why?
|
| Carbon | 22 | 2024 | 687 | 1.810 |
Why?
|
| Models, Theoretical | 28 | 2019 | 3589 | 1.780 |
Why?
|
| Asthma | 29 | 2024 | 6010 | 1.720 |
Why?
|
| Sulfur | 6 | 2020 | 166 | 1.530 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 15 | 2024 | 3047 | 1.380 |
Why?
|
| Climate Change | 8 | 2023 | 418 | 1.370 |
Why?
|
| Respiration Disorders | 5 | 2022 | 371 | 1.320 |
Why?
|
| Boston | 44 | 2021 | 9312 | 1.300 |
Why?
|
| Brazil | 14 | 2023 | 1270 | 1.280 |
Why?
|
| Massachusetts | 38 | 2023 | 8662 | 1.240 |
Why?
|
| Meteorology | 2 | 2022 | 10 | 1.220 |
Why?
|
| Hot Temperature | 7 | 2023 | 1356 | 1.180 |
Why?
|
| Toxicity Tests | 7 | 2011 | 121 | 1.160 |
Why?
|
| Atmosphere Exposure Chambers | 5 | 2011 | 50 | 1.120 |
Why?
|
| Cardiovascular Diseases | 20 | 2023 | 15160 | 1.070 |
Why?
|
| Satellite Communications | 6 | 2015 | 13 | 1.060 |
Why?
|
| Forced Expiratory Volume | 13 | 2023 | 1745 | 1.040 |
Why?
|
| Coal | 7 | 2017 | 119 | 1.030 |
Why?
|
| Beta Particles | 3 | 2020 | 50 | 1.010 |
Why?
|
| Humans | 301 | 2024 | 744366 | 0.990 |
Why?
|
| Heating | 5 | 2020 | 97 | 0.960 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2022 | 707 | 0.940 |
Why?
|
| Sulfates | 12 | 2024 | 390 | 0.900 |
Why?
|
| Extreme Heat | 1 | 2023 | 37 | 0.870 |
Why?
|
| Live Birth | 2 | 2023 | 512 | 0.840 |
Why?
|
| Gamma Rays | 3 | 2020 | 320 | 0.840 |
Why?
|
| Radiation Injuries | 2 | 2020 | 1180 | 0.830 |
Why?
|
| Petroleum | 2 | 2013 | 76 | 0.790 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 2022 | 1159 | 0.790 |
Why?
|
| Respiratory Sounds | 5 | 2019 | 696 | 0.770 |
Why?
|
| Metals, Heavy | 1 | 2022 | 139 | 0.760 |
Why?
|
| Maternal Exposure | 13 | 2022 | 961 | 0.760 |
Why?
|
| Abortion, Spontaneous | 2 | 2023 | 544 | 0.750 |
Why?
|
| Polonium | 1 | 2020 | 2 | 0.740 |
Why?
|
| Urban Health | 7 | 2017 | 547 | 0.740 |
Why?
|
| Carbon Monoxide | 9 | 2019 | 531 | 0.730 |
Why?
|
| Residence Characteristics | 12 | 2020 | 2050 | 0.730 |
Why?
|
| Environmental Pollutants | 3 | 2023 | 1179 | 0.710 |
Why?
|
| Inflammation | 13 | 2022 | 10637 | 0.700 |
Why?
|
| Oxidants, Photochemical | 4 | 2017 | 78 | 0.690 |
Why?
|
| Geographic Information Systems | 4 | 2017 | 281 | 0.680 |
Why?
|
| Vital Capacity | 6 | 2019 | 925 | 0.680 |
Why?
|
| United States | 62 | 2023 | 69872 | 0.680 |
Why?
|
| Photochemistry | 2 | 2011 | 238 | 0.680 |
Why?
|
| Lung | 19 | 2022 | 9857 | 0.670 |
Why?
|
| Models, Chemical | 7 | 2016 | 626 | 0.650 |
Why?
|
| Climate | 1 | 2019 | 147 | 0.650 |
Why?
|
| Heart Rate | 6 | 2022 | 4092 | 0.640 |
Why?
|
| Air Pollutants, Occupational | 5 | 2010 | 408 | 0.640 |
Why?
|
| Biofuels | 1 | 2018 | 41 | 0.630 |
Why?
|
| United States Environmental Protection Agency | 10 | 2020 | 139 | 0.630 |
Why?
|
| Leukocytes | 4 | 2021 | 2045 | 0.620 |
Why?
|
| Nitrogen Oxides | 10 | 2018 | 129 | 0.620 |
Why?
|
| Birth Weight | 10 | 2023 | 2069 | 0.610 |
Why?
|
| Urbanization | 2 | 2015 | 104 | 0.610 |
Why?
|
| Endothelium | 1 | 2020 | 778 | 0.600 |
Why?
|
| Aging | 14 | 2022 | 8664 | 0.600 |
Why?
|
| Blood Pressure | 11 | 2021 | 8551 | 0.590 |
Why?
|
| Aged | 85 | 2023 | 163288 | 0.580 |
Why?
|
| Models, Statistical | 11 | 2021 | 5101 | 0.570 |
Why?
|
| Humidity | 5 | 2019 | 197 | 0.560 |
Why?
|
| Filtration | 4 | 2015 | 234 | 0.560 |
Why?
|
| Male | 143 | 2023 | 350115 | 0.560 |
Why?
|
| China | 8 | 2024 | 2245 | 0.550 |
Why?
|
| Schools | 7 | 2021 | 1433 | 0.530 |
Why?
|
| Cause of Death | 4 | 2022 | 3582 | 0.530 |
Why?
|
| Oxidative Stress | 12 | 2023 | 3084 | 0.520 |
Why?
|
| Cyprus | 8 | 2023 | 79 | 0.520 |
Why?
|
| Linear Models | 25 | 2021 | 5953 | 0.500 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2020 | 489 | 0.500 |
Why?
|
| Regression Analysis | 19 | 2017 | 6459 | 0.500 |
Why?
|
| Cooking | 6 | 2019 | 313 | 0.500 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 996 | 0.500 |
Why?
|
| Smoke | 6 | 2024 | 227 | 0.480 |
Why?
|
| Nitrous Oxide | 1 | 2015 | 176 | 0.480 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2014 | 144 | 0.480 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2020 | 2269 | 0.460 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2021 | 2408 | 0.460 |
Why?
|
| Heart Diseases | 3 | 2016 | 2789 | 0.450 |
Why?
|
| Myocardial Ischemia | 2 | 2022 | 2148 | 0.440 |
Why?
|
| Female | 121 | 2024 | 380193 | 0.430 |
Why?
|
| Construction Materials | 2 | 2023 | 60 | 0.430 |
Why?
|
| Ethanol | 2 | 2019 | 1342 | 0.420 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 13104 | 0.420 |
Why?
|
| Rhinitis | 1 | 2019 | 691 | 0.410 |
Why?
|
| Child | 50 | 2024 | 77709 | 0.410 |
Why?
|
| Cohort Studies | 35 | 2023 | 40559 | 0.410 |
Why?
|
| Equipment Design | 9 | 2015 | 3582 | 0.410 |
Why?
|
| Wood | 4 | 2020 | 89 | 0.410 |
Why?
|
| Hospitalization | 15 | 2022 | 10259 | 0.400 |
Why?
|
| Cold Temperature | 4 | 2023 | 772 | 0.390 |
Why?
|
| Sulfur Dioxide | 6 | 2023 | 177 | 0.390 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 1200 | 0.390 |
Why?
|
| Pregnancy | 29 | 2024 | 29144 | 0.390 |
Why?
|
| Diabetes, Gestational | 2 | 2020 | 1184 | 0.380 |
Why?
|
| Greece | 6 | 2023 | 344 | 0.380 |
Why?
|
| Cough | 2 | 2014 | 555 | 0.380 |
Why?
|
| Time Factors | 28 | 2020 | 40075 | 0.370 |
Why?
|
| Endotoxins | 3 | 2015 | 527 | 0.370 |
Why?
|
| Infant, Low Birth Weight | 5 | 2022 | 850 | 0.370 |
Why?
|
| Air Movements | 6 | 2011 | 42 | 0.360 |
Why?
|
| Hydrocarbons | 4 | 2018 | 106 | 0.360 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 378 | 0.360 |
Why?
|
| New England | 7 | 2022 | 1022 | 0.350 |
Why?
|
| Aged, 80 and over | 34 | 2021 | 57776 | 0.340 |
Why?
|
| Urban Population | 13 | 2017 | 2022 | 0.340 |
Why?
|
| DNA Methylation | 8 | 2021 | 4285 | 0.330 |
Why?
|
| Canada | 6 | 2018 | 2065 | 0.330 |
Why?
|
| Cluster Analysis | 6 | 2019 | 2715 | 0.330 |
Why?
|
| Chile | 6 | 2013 | 237 | 0.330 |
Why?
|
| Nitrates | 4 | 2023 | 265 | 0.330 |
Why?
|
| Spores, Fungal | 3 | 1997 | 94 | 0.320 |
Why?
|
| Longitudinal Studies | 19 | 2024 | 13991 | 0.320 |
Why?
|
| Stroke | 7 | 2022 | 9981 | 0.310 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 961 | 0.310 |
Why?
|
| Dental Offices | 1 | 2007 | 13 | 0.310 |
Why?
|
| Coronary Disease | 2 | 2022 | 6077 | 0.300 |
Why?
|
| Respiratory Function Tests | 11 | 2023 | 1617 | 0.300 |
Why?
|
| Bayes Theorem | 6 | 2021 | 2307 | 0.300 |
Why?
|
| Bronchitis, Chronic | 3 | 2024 | 62 | 0.300 |
Why?
|
| Middle Aged | 58 | 2023 | 213390 | 0.290 |
Why?
|
| Afghanistan | 2 | 2017 | 81 | 0.290 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 5035 | 0.290 |
Why?
|
| Automobiles | 2 | 2018 | 116 | 0.280 |
Why?
|
| Volcanic Eruptions | 1 | 2006 | 17 | 0.280 |
Why?
|
| Middle East | 2 | 2017 | 219 | 0.280 |
Why?
|
| Young Adult | 21 | 2024 | 56429 | 0.270 |
Why?
|
| Polytetrafluoroethylene | 2 | 2020 | 233 | 0.270 |
Why?
|
| Activities of Daily Living | 5 | 2017 | 2419 | 0.270 |
Why?
|
| Risk Factors | 26 | 2020 | 72296 | 0.260 |
Why?
|
| Sports | 1 | 2012 | 688 | 0.260 |
Why?
|
| Adult | 54 | 2024 | 214052 | 0.260 |
Why?
|
| Motor Vehicles | 4 | 2017 | 268 | 0.250 |
Why?
|
| Gasoline | 3 | 2019 | 51 | 0.250 |
Why?
|
| C-Reactive Protein | 7 | 2022 | 3778 | 0.250 |
Why?
|
| Organic Chemicals | 5 | 2019 | 211 | 0.240 |
Why?
|
| Lead | 3 | 2022 | 852 | 0.240 |
Why?
|
| Laboratories | 2 | 2021 | 463 | 0.240 |
Why?
|
| Veterans | 4 | 2024 | 2519 | 0.240 |
Why?
|
| Metabolomics | 3 | 2021 | 1485 | 0.240 |
Why?
|
| Baltimore | 5 | 2009 | 231 | 0.240 |
Why?
|
| Midwestern United States | 1 | 2023 | 70 | 0.230 |
Why?
|
| Desert Climate | 1 | 2023 | 14 | 0.230 |
Why?
|
| Hyperemia | 2 | 2016 | 225 | 0.230 |
Why?
|
| Epigenesis, Genetic | 4 | 2019 | 3646 | 0.230 |
Why?
|
| Iraq | 2 | 2021 | 92 | 0.230 |
Why?
|
| Ventilation | 7 | 2006 | 127 | 0.230 |
Why?
|
| Adolescent | 25 | 2024 | 85779 | 0.230 |
Why?
|
| Gases | 6 | 2024 | 197 | 0.230 |
Why?
|
| Coronavirus 229E, Human | 1 | 2023 | 16 | 0.230 |
Why?
|
| Hypertension | 4 | 2020 | 8479 | 0.220 |
Why?
|
| Infant, Newborn | 16 | 2022 | 25628 | 0.220 |
Why?
|
| Rural Population | 5 | 2019 | 2207 | 0.220 |
Why?
|
| Droughts | 1 | 2022 | 28 | 0.220 |
Why?
|
| Quality Control | 3 | 2014 | 841 | 0.220 |
Why?
|
| Cross-Over Studies | 8 | 2024 | 2029 | 0.220 |
Why?
|
| Metals | 4 | 2016 | 719 | 0.210 |
Why?
|
| Nickel | 2 | 2020 | 130 | 0.210 |
Why?
|
| Connecticut | 5 | 2014 | 366 | 0.210 |
Why?
|
| Brachial Artery | 2 | 2014 | 369 | 0.210 |
Why?
|
| Odds Ratio | 9 | 2022 | 9849 | 0.210 |
Why?
|
| Calibration | 2 | 2017 | 816 | 0.210 |
Why?
|
| Premature Birth | 4 | 2021 | 1721 | 0.210 |
Why?
|
| Public Health | 8 | 2019 | 2602 | 0.200 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.200 |
Why?
|
| Administration, Inhalation | 3 | 2011 | 1105 | 0.200 |
Why?
|
| Georgia | 3 | 2011 | 186 | 0.200 |
Why?
|
| Ultraviolet Rays | 2 | 2023 | 1060 | 0.200 |
Why?
|
| Leukocyte Count | 3 | 2021 | 1588 | 0.200 |
Why?
|
| Fires | 1 | 2023 | 173 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2019 | 8300 | 0.190 |
Why?
|
| Malaysia | 1 | 2021 | 92 | 0.190 |
Why?
|
| Formaldehyde | 2 | 2022 | 353 | 0.190 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 19905 | 0.190 |
Why?
|
| Population Density | 2 | 2018 | 196 | 0.190 |
Why?
|
| Facility Design and Construction | 1 | 2001 | 87 | 0.190 |
Why?
|
| California | 2 | 2022 | 1402 | 0.190 |
Why?
|
| Risk Assessment | 11 | 2021 | 23336 | 0.180 |
Why?
|
| Hypersensitivity | 2 | 2019 | 1102 | 0.180 |
Why?
|
| Blood Pressure Determination | 3 | 2020 | 633 | 0.170 |
Why?
|
| Autonomic Nervous System | 2 | 2017 | 672 | 0.170 |
Why?
|
| Kerosene | 1 | 1999 | 15 | 0.170 |
Why?
|
| Child, Preschool | 13 | 2021 | 41005 | 0.170 |
Why?
|
| Diabetes Mellitus | 3 | 2017 | 5749 | 0.170 |
Why?
|
| Occupational Exposure | 2 | 2024 | 1793 | 0.170 |
Why?
|
| Epigenomics | 4 | 2017 | 903 | 0.170 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2000 | 316 | 0.170 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 237 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2022 | 894 | 0.170 |
Why?
|
| Plant Extracts | 1 | 2022 | 471 | 0.170 |
Why?
|
| Ecosystem | 1 | 2023 | 474 | 0.160 |
Why?
|
| Heart Failure | 1 | 2022 | 10895 | 0.160 |
Why?
|
| Cross-Sectional Studies | 8 | 2024 | 25039 | 0.160 |
Why?
|
| Hospitals | 4 | 2022 | 3954 | 0.160 |
Why?
|
| Air Conditioning | 2 | 2017 | 50 | 0.160 |
Why?
|
| Hospitals, Veterans | 1 | 2021 | 404 | 0.160 |
Why?
|
| Spain | 1 | 2019 | 465 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 11726 | 0.160 |
Why?
|
| Rats | 11 | 2019 | 24252 | 0.160 |
Why?
|
| Health Status Disparities | 2 | 2020 | 1796 | 0.160 |
Why?
|
| Statistics as Topic | 3 | 2014 | 2373 | 0.160 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2018 | 440 | 0.160 |
Why?
|
| Death | 1 | 2022 | 678 | 0.150 |
Why?
|
| Child Welfare | 1 | 2002 | 523 | 0.150 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2017 | 7 | 0.150 |
Why?
|
| Pest Control | 1 | 2017 | 30 | 0.150 |
Why?
|
| Patient Admission | 2 | 2016 | 1380 | 0.150 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.150 |
Why?
|
| Diffusion | 2 | 2011 | 832 | 0.150 |
Why?
|
| Metabolome | 2 | 2021 | 895 | 0.150 |
Why?
|
| Fuel Oils | 1 | 2017 | 34 | 0.150 |
Why?
|
| Melatonin | 1 | 2023 | 721 | 0.150 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 527 | 0.150 |
Why?
|
| Respiratory System | 2 | 2020 | 557 | 0.140 |
Why?
|
| Myocardial Infarction | 4 | 2022 | 11718 | 0.140 |
Why?
|
| Medicare | 8 | 2023 | 6566 | 0.140 |
Why?
|
| Infant | 10 | 2022 | 35134 | 0.140 |
Why?
|
| Organizations, Nonprofit | 1 | 2017 | 104 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 163 | 0.140 |
Why?
|
| Mining | 1 | 2017 | 88 | 0.140 |
Why?
|
| Neutrophils | 5 | 2021 | 3721 | 0.140 |
Why?
|
| Environment | 4 | 2018 | 1123 | 0.140 |
Why?
|
| Volatilization | 2 | 2006 | 82 | 0.140 |
Why?
|
| Spirometry | 4 | 2023 | 865 | 0.140 |
Why?
|
| Autopsy | 1 | 2020 | 1020 | 0.140 |
Why?
|
| Dinoprost | 1 | 2016 | 138 | 0.140 |
Why?
|
| Brain | 3 | 2020 | 26388 | 0.130 |
Why?
|
| Industry | 2 | 2017 | 365 | 0.130 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 314 | 0.130 |
Why?
|
| Risk | 5 | 2022 | 9688 | 0.130 |
Why?
|
| Altitude | 1 | 2016 | 161 | 0.130 |
Why?
|
| Logistic Models | 12 | 2020 | 13409 | 0.130 |
Why?
|
| Adipokines | 1 | 2017 | 320 | 0.130 |
Why?
|
| Geography | 2 | 2014 | 669 | 0.130 |
Why?
|
| Interleukin-6 | 4 | 2018 | 3203 | 0.130 |
Why?
|
| Poisson Distribution | 2 | 2014 | 513 | 0.130 |
Why?
|
| Light | 2 | 2023 | 1374 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1695 | 0.130 |
Why?
|
| Pulsatile Flow | 1 | 2016 | 332 | 0.130 |
Why?
|
| Brugada Syndrome | 1 | 2016 | 97 | 0.130 |
Why?
|
| Argentina | 1 | 2015 | 232 | 0.120 |
Why?
|
| Adsorption | 1 | 2015 | 201 | 0.120 |
Why?
|
| Environmental Illness | 1 | 2014 | 34 | 0.120 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 288 | 0.120 |
Why?
|
| Elements | 2 | 2017 | 20 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 123 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2265 | 0.120 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3046 | 0.120 |
Why?
|
| Coronary Artery Disease | 4 | 2017 | 6486 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 2732 | 0.120 |
Why?
|
| Air | 1 | 2014 | 182 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 209 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2015 | 4196 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2020 | 1532 | 0.120 |
Why?
|
| Pneumonia | 3 | 2019 | 2133 | 0.120 |
Why?
|
| Radon Daughters | 2 | 2023 | 11 | 0.120 |
Why?
|
| Total Lung Capacity | 1 | 2013 | 143 | 0.120 |
Why?
|
| School Health Services | 1 | 2017 | 375 | 0.120 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 1150 | 0.120 |
Why?
|
| Cytosine | 1 | 2015 | 216 | 0.110 |
Why?
|
| Allergens | 2 | 2021 | 1320 | 0.110 |
Why?
|
| Uncertainty | 2 | 2020 | 735 | 0.110 |
Why?
|
| Folic Acid | 2 | 2017 | 1300 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 391 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1739 | 0.110 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2014 | 188 | 0.110 |
Why?
|
| Gestational Age | 3 | 2023 | 3493 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1364 | 0.110 |
Why?
|
| Prospective Studies | 14 | 2022 | 53290 | 0.110 |
Why?
|
| Cross Infection | 1 | 2022 | 1417 | 0.110 |
Why?
|
| Peroxidase | 1 | 2016 | 611 | 0.110 |
Why?
|
| Fingers | 1 | 2016 | 513 | 0.110 |
Why?
|
| Tandem Repeat Sequences | 1 | 2013 | 185 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2017 | 754 | 0.110 |
Why?
|
| Socioeconomic Factors | 5 | 2020 | 7785 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 520 | 0.110 |
Why?
|
| Circadian Rhythm | 4 | 2023 | 2624 | 0.110 |
Why?
|
| Overweight | 1 | 2024 | 2371 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2020 | 831 | 0.110 |
Why?
|
| Prevalence | 5 | 2019 | 15221 | 0.100 |
Why?
|
| Israel | 3 | 2023 | 796 | 0.100 |
Why?
|
| Nicotine | 1 | 2017 | 681 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2166 | 0.100 |
Why?
|
| Environmental Policy | 1 | 2012 | 33 | 0.100 |
Why?
|
| Stainless Steel | 1 | 2011 | 80 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2076 | 0.100 |
Why?
|
| Microvessels | 1 | 2016 | 544 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2017 | 727 | 0.100 |
Why?
|
| Animals | 23 | 2019 | 168768 | 0.100 |
Why?
|
| New York City | 1 | 2013 | 710 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 808 | 0.100 |
Why?
|
| Africa, Northern | 2 | 2021 | 82 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2022 | 6442 | 0.100 |
Why?
|
| Disease Susceptibility | 2 | 2010 | 1782 | 0.100 |
Why?
|
| Drug Industry | 1 | 2017 | 746 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 570 | 0.100 |
Why?
|
| Porosity | 1 | 2011 | 362 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 601 | 0.090 |
Why?
|
| Life Style | 2 | 2019 | 3835 | 0.090 |
Why?
|
| Environment Design | 1 | 2012 | 178 | 0.090 |
Why?
|
| Potassium | 1 | 2015 | 1336 | 0.090 |
Why?
|
| Sulfur Oxides | 1 | 2010 | 10 | 0.090 |
Why?
|
| Meteorological Concepts | 2 | 2008 | 30 | 0.090 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2010 | 23 | 0.090 |
Why?
|
| Peak Expiratory Flow Rate | 4 | 1999 | 141 | 0.090 |
Why?
|
| Microcirculation | 1 | 2014 | 1287 | 0.090 |
Why?
|
| Qatar | 2 | 2019 | 36 | 0.090 |
Why?
|
| Skin | 1 | 2023 | 4372 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 577 | 0.090 |
Why?
|
| Vasodilation | 1 | 2014 | 944 | 0.090 |
Why?
|
| Lung Diseases | 3 | 2014 | 1887 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 1504 | 0.080 |
Why?
|
| Aorta | 1 | 2017 | 2062 | 0.080 |
Why?
|
| New Hampshire | 2 | 2020 | 172 | 0.080 |
Why?
|
| Optical Devices | 1 | 2009 | 37 | 0.080 |
Why?
|
| Restaurants | 1 | 2011 | 236 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 255 | 0.080 |
Why?
|
| Causality | 1 | 2015 | 1275 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 367 | 0.080 |
Why?
|
| Family Characteristics | 1 | 2014 | 1000 | 0.080 |
Why?
|
| Ohio | 1 | 2009 | 337 | 0.080 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12356 | 0.080 |
Why?
|
| Single-Blind Method | 3 | 2017 | 1590 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2018 | 3486 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1888 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2022 | 77460 | 0.080 |
Why?
|
| Air Microbiology | 2 | 2021 | 87 | 0.080 |
Why?
|
| Incidence | 5 | 2023 | 20952 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1499 | 0.080 |
Why?
|
| Age Factors | 4 | 2018 | 18373 | 0.080 |
Why?
|
| Dental Equipment | 1 | 2007 | 11 | 0.080 |
Why?
|
| Dental Instruments | 1 | 2007 | 17 | 0.080 |
Why?
|
| Independent Living | 1 | 2012 | 568 | 0.080 |
Why?
|
| Executive Function | 1 | 2016 | 1364 | 0.070 |
Why?
|
| Stress, Psychological | 2 | 2015 | 4245 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 620 | 0.070 |
Why?
|
| Sex Factors | 2 | 2018 | 10400 | 0.070 |
Why?
|
| Morbidity | 2 | 2023 | 1768 | 0.070 |
Why?
|
| Glutathione Reductase | 1 | 2006 | 25 | 0.070 |
Why?
|
| Histones | 1 | 2016 | 2598 | 0.070 |
Why?
|
| Forecasting | 2 | 2014 | 2951 | 0.070 |
Why?
|
| Epidemiologic Studies | 3 | 2006 | 676 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 3 | 2015 | 2716 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2024 | 12721 | 0.070 |
Why?
|
| North Carolina | 2 | 2017 | 315 | 0.070 |
Why?
|
| Dyspnea | 2 | 2024 | 1303 | 0.070 |
Why?
|
| Nitric Oxide | 3 | 2023 | 2132 | 0.070 |
Why?
|
| Defibrillators, Implantable | 2 | 2005 | 1440 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2020 | 6254 | 0.070 |
Why?
|
| Glucose | 1 | 2017 | 4398 | 0.070 |
Why?
|
| Southeastern United States | 2 | 2015 | 95 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2017 | 7730 | 0.070 |
Why?
|
| Respiration | 1 | 2012 | 1653 | 0.060 |
Why?
|
| Health Behavior | 1 | 2017 | 2635 | 0.060 |
Why?
|
| Pollen | 3 | 2006 | 75 | 0.060 |
Why?
|
| Fetal Development | 2 | 2023 | 767 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1188 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2001 | 2556 | 0.060 |
Why?
|
| Sulfuric Acids | 3 | 2001 | 37 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 255 | 0.060 |
Why?
|
| Depression | 2 | 2015 | 7759 | 0.060 |
Why?
|
| Algorithms | 6 | 2020 | 13882 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2293 | 0.060 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2009 | 536 | 0.060 |
Why?
|
| Bronchitis | 3 | 2000 | 200 | 0.060 |
Why?
|
| Bronchodilator Agents | 2 | 2018 | 502 | 0.060 |
Why?
|
| Propensity Score | 2 | 2021 | 1781 | 0.060 |
Why?
|
| Pilot Projects | 5 | 2017 | 8319 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 596 | 0.060 |
Why?
|
| Soil | 1 | 2023 | 106 | 0.060 |
Why?
|
| Heart | 2 | 2019 | 4464 | 0.060 |
Why?
|
| Manometry | 2 | 2016 | 445 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 264 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 12262 | 0.050 |
Why?
|
| Developing Countries | 1 | 2015 | 2815 | 0.050 |
Why?
|
| Household Products | 1 | 2022 | 26 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13286 | 0.050 |
Why?
|
| Fossil Fuels | 1 | 2022 | 44 | 0.050 |
Why?
|
| Polyurethanes | 1 | 2002 | 107 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2213 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2023 | 538 | 0.050 |
Why?
|
| Immunoglobulin E | 2 | 2018 | 1463 | 0.050 |
Why?
|
| Acids | 2 | 1993 | 127 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 206 | 0.050 |
Why?
|
| Mali | 1 | 2021 | 44 | 0.050 |
Why?
|
| Social Mobility | 1 | 2021 | 31 | 0.050 |
Why?
|
| Europe, Eastern | 1 | 2021 | 75 | 0.050 |
Why?
|
| Dogs | 4 | 2015 | 3912 | 0.050 |
Why?
|
| Stillbirth | 1 | 2024 | 346 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 875 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2015 | 1423 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 690 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 205 | 0.050 |
Why?
|
| Creatinine | 2 | 2016 | 1919 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 4034 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2021 | 379 | 0.050 |
Why?
|
| Vasoconstriction | 1 | 2002 | 597 | 0.040 |
Why?
|
| Ammonia | 2 | 2006 | 239 | 0.040 |
Why?
|
| Wind | 1 | 2019 | 38 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7658 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2012 | 768 | 0.040 |
Why?
|
| Fungi | 1 | 2022 | 327 | 0.040 |
Why?
|
| Virginia | 1 | 1999 | 121 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2001 | 407 | 0.040 |
Why?
|
| Environmental Health | 2 | 2017 | 278 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 12746 | 0.040 |
Why?
|
| Biomass | 1 | 2019 | 125 | 0.040 |
Why?
|
| Research Design | 3 | 2024 | 5984 | 0.040 |
Why?
|
| Registries | 3 | 2019 | 8091 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4772 | 0.040 |
Why?
|
| Specimen Handling | 2 | 2001 | 694 | 0.040 |
Why?
|
| Nitric Acid | 2 | 1996 | 10 | 0.040 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2017 | 28 | 0.040 |
Why?
|
| Cytokines | 2 | 2023 | 7323 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3265 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2001 | 14723 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 6770 | 0.040 |
Why?
|
| Menthol | 1 | 2017 | 26 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3611 | 0.040 |
Why?
|
| Eosinophils | 1 | 2022 | 955 | 0.040 |
Why?
|
| Breath Tests | 1 | 2018 | 280 | 0.040 |
Why?
|
| Protein Modification, Translational | 1 | 2016 | 21 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 954 | 0.040 |
Why?
|
| Noise, Transportation | 1 | 2017 | 50 | 0.040 |
Why?
|
| Fund Raising | 1 | 2017 | 47 | 0.040 |
Why?
|
| Rhode Island | 1 | 2017 | 347 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 211 | 0.040 |
Why?
|
| Mountaineering | 1 | 2016 | 45 | 0.040 |
Why?
|
| Health Surveys | 2 | 2019 | 4036 | 0.040 |
Why?
|
| Methane | 1 | 2016 | 51 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2016 | 25 | 0.040 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2016 | 46 | 0.030 |
Why?
|
| Sleep | 1 | 2012 | 4622 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 1273 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2002 | 2617 | 0.030 |
Why?
|
| Marital Status | 1 | 2017 | 437 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 84 | 0.030 |
Why?
|
| Denmark | 1 | 2018 | 738 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 221 | 0.030 |
Why?
|
| Nepal | 1 | 2016 | 295 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 766 | 0.030 |
Why?
|
| Skin Tests | 1 | 2017 | 613 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 357 | 0.030 |
Why?
|
| Computer Simulation | 3 | 2015 | 6194 | 0.030 |
Why?
|
| Disease Models, Animal | 6 | 2016 | 18034 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 856 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
| Maternal Age | 1 | 2017 | 802 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 20824 | 0.030 |
Why?
|
| Mid-Atlantic Region | 1 | 2014 | 23 | 0.030 |
Why?
|
| Pulse | 1 | 2014 | 229 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 154 | 0.030 |
Why?
|
| Hazardous Substances | 1 | 2015 | 149 | 0.030 |
Why?
|
| Developed Countries | 1 | 2017 | 437 | 0.030 |
Why?
|
| Gambia | 1 | 2014 | 98 | 0.030 |
Why?
|
| Silicon | 1 | 2014 | 145 | 0.030 |
Why?
|
| Aluminum | 1 | 2014 | 152 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1912 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 119 | 0.030 |
Why?
|
| Vitamin E | 1 | 2018 | 869 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 1680 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1084 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 1106 | 0.030 |
Why?
|
| Nitrites | 1 | 1994 | 160 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 683 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2004 | 2948 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2901 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 381 | 0.030 |
Why?
|
| Term Birth | 1 | 2014 | 135 | 0.030 |
Why?
|
| Public Health Administration | 1 | 2015 | 240 | 0.030 |
Why?
|
| Research | 2 | 2017 | 1999 | 0.030 |
Why?
|
| Ghana | 1 | 2014 | 284 | 0.030 |
Why?
|
| World Health Organization | 1 | 2018 | 1318 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1771 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2014 | 2971 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2004 | 120 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 338 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 571 | 0.030 |
Why?
|
| Occupations | 1 | 2014 | 517 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1996 | 686 | 0.030 |
Why?
|
| Pandemics | 2 | 2023 | 8385 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 1007 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15078 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2015 | 837 | 0.030 |
Why?
|
| Thromboplastin | 1 | 2014 | 291 | 0.030 |
Why?
|
| Incineration | 2 | 2001 | 20 | 0.030 |
Why?
|
| Health Services | 1 | 2017 | 758 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 817 | 0.030 |
Why?
|
| Titanium | 1 | 2014 | 494 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 354 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 591 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 985 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2014 | 427 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2012 | 403 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 980 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 458 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15535 | 0.020 |
Why?
|
| Atrophy | 1 | 2015 | 1584 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 936 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 1011 | 0.020 |
Why?
|
| Plethysmography | 1 | 2010 | 180 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2018 | 1609 | 0.020 |
Why?
|
| Educational Status | 1 | 2017 | 2540 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
| Acid Rain | 1 | 1989 | 5 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2015 | 6366 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1170 | 0.020 |
Why?
|
| Quality of Life | 2 | 2024 | 12802 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2016 | 3689 | 0.020 |
Why?
|
| Ligands | 1 | 2016 | 3282 | 0.020 |
Why?
|
| Respiratory Rate | 1 | 2010 | 162 | 0.020 |
Why?
|
| Medicaid | 1 | 2022 | 2737 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 5388 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4222 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 5895 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3680 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2006 | 23 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 9955 | 0.020 |
Why?
|
| Spores | 1 | 2006 | 15 | 0.020 |
Why?
|
| Ischemia | 1 | 2016 | 1907 | 0.020 |
Why?
|
| Adiposity | 1 | 2016 | 1806 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3339 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12244 | 0.020 |
Why?
|
| Los Angeles | 1 | 2006 | 238 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20130 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2018 | 3296 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1905 | 0.020 |
Why?
|
| France | 1 | 2006 | 517 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3207 | 0.020 |
Why?
|
| Government Regulation | 1 | 2009 | 522 | 0.020 |
Why?
|
| Health Promotion | 1 | 2017 | 2205 | 0.020 |
Why?
|
| DNA Repair | 1 | 2014 | 2046 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2009 | 764 | 0.020 |
Why?
|
| Lipids | 1 | 2016 | 3307 | 0.020 |
Why?
|
| Macrophages | 1 | 2019 | 5660 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6933 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2022 | 21748 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4576 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 2045 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2004 | 240 | 0.010 |
Why?
|
| Pennsylvania | 2 | 1996 | 613 | 0.010 |
Why?
|
| Models, Biological | 3 | 2012 | 9584 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2004 | 198 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5218 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 2795 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39052 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2009 | 1534 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 240 | 0.010 |
Why?
|
| Hippocampus | 1 | 2015 | 3675 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 3922 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4805 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Household Articles | 1 | 2001 | 24 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 370 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5856 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2009 | 2740 | 0.010 |
Why?
|
| Calcium | 1 | 2014 | 5755 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Disinfectants | 1 | 2001 | 116 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2001 | 361 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10483 | 0.010 |
Why?
|
| Agriculture | 1 | 2001 | 186 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16690 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12025 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 675 | 0.010 |
Why?
|
| Philadelphia | 1 | 1999 | 267 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2003 | 705 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1999 | 424 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4424 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2001 | 977 | 0.010 |
Why?
|
| District of Columbia | 1 | 1997 | 157 | 0.010 |
Why?
|
| Smoking | 1 | 2013 | 8987 | 0.010 |
Why?
|
| Cell Count | 1 | 1999 | 1856 | 0.010 |
Why?
|
| Mexico | 1 | 1997 | 689 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.010 |
Why?
|
| Common Cold | 1 | 1995 | 61 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1607 | 0.010 |
Why?
|
| Mice | 2 | 2016 | 81201 | 0.010 |
Why?
|
| Ontario | 1 | 1995 | 383 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 3339 | 0.010 |
Why?
|
| Epidemiology | 1 | 1996 | 287 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23404 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
| Maximum Allowable Concentration | 1 | 1989 | 62 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 35425 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1999 | 9145 | 0.000 |
Why?
|
| Acute Disease | 1 | 1994 | 7147 | 0.000 |
Why?
|